36 related articles for article (PubMed ID: 16262974)
1. Development and application of Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS): an Australian economic model for stroke.
Mihalopoulos C; Cadilhac DA; Moodie ML; Dewey HM; Thrift AG; Donnan GA; Carter RC
Int J Technol Assess Health Care; 2005; 21(4):499-505. PubMed ID: 16262974
[TBL] [Abstract][Full Text] [Related]
2. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
Whitfield MD; Gillett M; Holmes M; Ogden E
Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
[TBL] [Abstract][Full Text] [Related]
3. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke.
Moodie ML; Carter R; Mihalopoulos C; Thrift AG; Chambers BR; Donnan GA; Dewey HM
Stroke; 2004 May; 35(5):1041-6. PubMed ID: 15031457
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
Pelletier EM; Shim B; Goodman S; Amonkar MM
Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
[TBL] [Abstract][Full Text] [Related]
5. A health economic model to determine the long-term costs and clinical outcomes of raising low HDL-cholesterol in the prevention of coronary heart disease.
Roze S; Liens D; Palmer A; Berger W; Tucker D; Renaudin C
Curr Med Res Opin; 2006 Dec; 22(12):2549-56. PubMed ID: 17166337
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
Mullins CD; Rattinger GB; Kuznik A; Koren MJ
Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
[TBL] [Abstract][Full Text] [Related]
7. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
8. Acute treatment costs of intracerebral hemorrhage and ischemic stroke in Argentina.
Christensen MC; Previgliano I; Capparelli FJ; Lerman D; Lee WC; Wainsztein NA
Acta Neurol Scand; 2009 Apr; 119(4):246-53. PubMed ID: 18771525
[TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of community-based physical activity interventions.
Roux L; Pratt M; Tengs TO; Yore MM; Yanagawa TL; Van Den Bos J; Rutt C; Brownson RC; Powell KE; Heath G; Kohl HW; Teutsch S; Cawley J; Lee IM; West L; Buchner DM
Am J Prev Med; 2008 Dec; 35(6):578-88. PubMed ID: 19000846
[TBL] [Abstract][Full Text] [Related]
10. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura.
Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R
Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109
[TBL] [Abstract][Full Text] [Related]
11. Costs of stroke using patient-level data: a critical review of the literature.
Luengo-Fernandez R; Gray AM; Rothwell PM
Stroke; 2009 Feb; 40(2):e18-23. PubMed ID: 19109540
[TBL] [Abstract][Full Text] [Related]
12. A national economic and clinical model for ischemic stroke care development in Saudi Arabia: A call for change.
Al-Senani F; Al-Johani M; Salawati M; ElSheikh S; AlQahtani M; Muthana J; AlZahrani S; Shore J; Taylor M; Ravest VS; Eggington S; Cuche M; Davies H; Lobotesis K; Saver JL
Int J Stroke; 2019 Oct; 14(8):835-842. PubMed ID: 31122171
[TBL] [Abstract][Full Text] [Related]
13. A cost simulation for mammography examinations taking into account equipment failures and resource utilization characteristics.
Coelli FC; Almeida RM; Pereira WC
J Eval Clin Pract; 2010 Dec; 16(6):1198-202. PubMed ID: 20695955
[TBL] [Abstract][Full Text] [Related]
14. The potential health and economic impact of improving stroke care standards for Australia.
Kim J; Andrew NE; Thrift AG; Bernhardt J; Lindley RI; Cadilhac DA
Int J Stroke; 2017 Oct; 12(8):875-885. PubMed ID: 28946831
[TBL] [Abstract][Full Text] [Related]
15. Is nonadmission-based care for TIA patients cost-effective?: A microcosting study.
Sanders LM; Cadilhac DA; Srikanth VK; Chong CP; Phan TG
Neurol Clin Pract; 2015 Feb; 5(1):58-66. PubMed ID: 29443173
[TBL] [Abstract][Full Text] [Related]
16. A systematic review of whole disease models for informing healthcare resource allocation decisions.
Jin H; Tappenden P; Ling X; Robinson S; Byford S
PLoS One; 2023; 18(9):e0291366. PubMed ID: 37708188
[TBL] [Abstract][Full Text] [Related]
17. Economic Evaluation of a Pre-Hospital Protocol for Patients with Suspected Acute Stroke.
Lahiry S; Levi C; Kim J; Cadilhac DA; Searles A
Front Public Health; 2018; 6():43. PubMed ID: 29552550
[TBL] [Abstract][Full Text] [Related]
18. Using risk models to improve patient selection for high-risk vascular surgery.
Goodney PP
Scientifica (Cairo); 2012; 2012():132370. PubMed ID: 24278669
[TBL] [Abstract][Full Text] [Related]
19. How to include informal care in economic evaluations.
Hoefman RJ; van Exel J; Brouwer W
Pharmacoeconomics; 2013 Dec; 31(12):1105-19. PubMed ID: 24218135
[TBL] [Abstract][Full Text] [Related]
20. Young stroke mortality in fiji islands: an economic analysis of national human capital resource loss.
Maharaj JC; Reddy M
ISRN Neurol; 2012; 2012():802785. PubMed ID: 22778993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
